Milestone Pharmaceuticals Inc
(MIST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,110 | -10,452 | -23,185 | -13,469 | -7,769 |
| Depreciation Amortization | 5 | 3 | 10 | 8 | 5 |
| Other Working Capital | -2,633 | -4,495 | 1,496 | -563 | -584 |
| Other Operating Activity | 487 | 211 | 633 | 289 | 204 |
| Operating Cash Flow | $-26,251 | $-14,733 | $-21,046 | $-13,735 | $-8,144 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -34,971 | N/A | 16,003 | 7,018 | 15,035 |
| PPE Investments | -18 | N/A | -5 | -5 | -5 |
| Investing Cash Flow | $-34,989 | $N/A | $15,998 | $7,013 | $15,030 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 86,117 | 25 | 461 | 37 | 37 |
| Other Financing Activity | 0 | 0 | 79,654 | 0 | 0 |
| Financing Cash Flow | $86,117 | $25 | $80,115 | $37 | $37 |
| Beginning Cash Position | 85,947 | 85,947 | 10,880 | 10,880 | 10,880 |
| End Cash Position | 110,824 | 71,239 | 85,947 | 4,195 | 17,803 |
| Net Cash Flow | $24,877 | $-14,708 | $75,067 | $-6,685 | $6,923 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,251 | -14,733 | -21,046 | -13,735 | -8,144 |
| Capital Expenditure | -18 | N/A | -5 | -5 | -5 |
| Free Cash Flow | -26,269 | -14,733 | -21,051 | -13,740 | -8,149 |